JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases
- Conditions
- Large B-cell LymphomaLupus Erythematosus, SystemicB-cell TumorsAutoimmune Diseases
- Interventions
- Biological: JWCAR201
- First Posted Date
- 2024-08-22
- Last Posted Date
- 2024-08-22
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT06567080
- Locations
- 🇨🇳
Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
Surufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine Differentiation
- Conditions
- ESCCBiliary Tract CancerGastric CancerPancreas Cancer
- Interventions
- First Posted Date
- 2024-07-31
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT06531291
- Locations
- 🇨🇳
Renji hospital, Shanghai, Shanghai, China
DRug-coAted Balloon Compared With cuttinG balloON in Treatment of Arteriovenous Fistula Stenosis
- Conditions
- Arteriovenous FistulaAngioplasty, BalloonHemodialysis Access Failure
- First Posted Date
- 2024-07-30
- Last Posted Date
- 2024-07-30
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 180
- Registration Number
- NCT06527963
- Locations
- 🇨🇳
First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
🇨🇳The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
🇨🇳Renji Hospital, Shanghai, Shanghai, China
Prospective Real-World Study of HAIC With Raltitrexed or 5-Fluorouracil for the Treatment of Hepatocellular Carcinoma
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Drug: hepatic artery infusion chemotherapy
- First Posted Date
- 2024-07-25
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 1115
- Registration Number
- NCT06519578
- Locations
- 🇨🇳
Deparment of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
🇨🇳Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
Safety and Efficacy Study of Lenvatinib Combined With VIC-1911 for the Treatment of Advanced HCC
- Conditions
- Hepatocellular Carcinoma
- Interventions
- First Posted Date
- 2024-07-25
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT06519721
- Locations
- 🇨🇳
Deparment of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
A Study of Enhancing Drug Prophylaxis of Venous Thromboembolism in Chinese Colorectal Cancer Surgery
- First Posted Date
- 2024-07-22
- Last Posted Date
- 2024-07-22
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 914
- Registration Number
- NCT06513481
Neoadjuvant Therapy With Weekly Utidelone Combined With Cisplatin for Patients With Breast Cancer (NeoURANIA)
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2024-07-19
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 143
- Registration Number
- NCT06510465
- Locations
- 🇨🇳
Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China
🇨🇳Renji Hospital, Shanghai, China
Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)
- First Posted Date
- 2024-07-19
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 21
- Registration Number
- NCT06511349
- Locations
- 🇨🇳
Deparment of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China
OXiris for Abdominal SEptic Shock (OASES Study)
- Conditions
- Septic ShockBlood PurificationMulti Organ FailureAbdominal SepsisAKI - Acute Kidney Injury
- Interventions
- Device: CRRT filter
- First Posted Date
- 2024-07-16
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 192
- Registration Number
- NCT06504316
- Locations
- 🇨🇳
Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China
Effectiveness of Endoluminal Treatment of Autologous Arteriovenous Endovascular Fistula Failure
- Conditions
- Hemodialysis Access Failure
- First Posted Date
- 2024-07-09
- Last Posted Date
- 2024-07-09
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 180
- Registration Number
- NCT06493292
- Locations
- 🇨🇳
Renji Hospital, Shanghai, Shanghai, China
🇨🇳First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
🇨🇳The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China